{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:48:47Z","timestamp":1790380127365,"version":"4.1.0"},"reference-count":27,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2015,11,6]]},"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Several studies have identified circulating biomarkers to be associated with the presence and severity of pulmonary arterial hypertension (PAH). Recent evidence supports a role for galectin-3 (Gal-3) and the mineralcorticoid aldosterone in left ventricular failure. However, studies on aldosterone together with Gal-3 in PAH are lacking.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>We investigated a novel Aldosterone-galectin-3 (Gal-3) tandem and several other potential PAH biomarkers and their association with the disease severity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 57 patients, 41 with idiopathic PAH. (IPAH) and 16 with PAH associated with connective tissue disease (CTD), and 8 age-matched, non-relative controls were studied. Gal-3, aldosterone and other potential protein plasma concentrations were measured by single ELISA and multi-array MSD (Meso Scale Discovery) technology.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Gal-3 values were increased in both patients with IPAH (12.2\u00b10.6\u2005ng\/mL; p&lt;0.05) and with PAH-CTD (14.1\u00b11.6\u2005ng\/mL; p&lt;0.05) versus control (8.5\u00b10.9\u2005ng\/mL), while aldosterone was significantly elevated in IPAH only (248.5\u00b138.8\u2005pg\/mL vs control 71.9\u00b118.2\u2005pg\/mL; p&lt;0.05). In addition, aldosterone, Gal-3, and N-terminal pro-brain natriuretic peptide (NT-proBNP) values were all higher in patients in WHO functional class II\u2013III versus PAH functional class I or controls. The vascular injury marker intercellular adhesion molecule 1 (ICAM-1) was increased in IPAH and PAH-CTD versus controls (559.5\u00b118.2\u2005pg\/mL and 734.1\u00b159.4\u2005pg\/mL vs controls 394.8\u00b139.3\u2005pg\/mL, p&lt;0.05, p&lt;0.0001, respectively), whereas vascular cell adhesion molecule 1 (VCAM-1) and proinflammatory, anti-angiogenic interleukin-12 (IL-12) were elevated in PAH-CTD only (879.5\u00b1110.0\u2005pg\/mL and 391.2\u00b170.3\u2005pg\/mL vs controls 489.8\u00b144.6\u2005pg\/mL, p&lt;0.01, and 102.1\u00b115.2\u2005pg\/mL, p&lt;0.01, respectively).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Heightened Gal-3 and aldosterone plasma concentrations in PAH patients indicate a role for Gal-3 signalling in the pathobiology of IPAH and PAH-CTD, and may serve as biomarkers for functional status and progression of disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2015-308365","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T17:09:09Z","timestamp":1455210549000},"page":"390-396","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":82,"title":["Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension"],"prefix":"10.1136","volume":"102","author":[{"given":"Laurent","family":"Calvier","sequence":"first","affiliation":[{"name":"Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Legchenko","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Grimm","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Sallmon","sequence":"additional","affiliation":[{"name":"Department of Neonatology, Charit\u00e9 University Medical Center, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Hatch","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Northeastern University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D","family":"Plouffe","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Northeastern University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schroeder","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Bauersachs","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi K","family":"Murthy","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Northeastern University, Boston, Massachusetts, USA"},{"name":"Barnett Institute of Chemical and Biological Analysis, Northeastern University, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Hansmann","sequence":"additional","affiliation":[{"name":"Department of Pediatric Cardiology and Critical Care, Hannover Medical School, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,2,10]]},"reference":[{"key":"2025101721324044000_102.5.390.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.025"},{"key":"2025101721324044000_102.5.390.2","doi-asserted-by":"crossref","unstructured":"Gali\u00e8 N , Humbert M , Vachiery JL , et al . 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2015 Aug 29. pii: ehv317. doi:10.1183\/13993003.01032-2015","DOI":"10.1183\/13993003.01032-2015"},{"key":"2025101721324044000_102.5.390.3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000329"},{"key":"2025101721324044000_102.5.390.4","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005428"},{"key":"2025101721324044000_102.5.390.5","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-011-0779-6"},{"key":"2025101721324044000_102.5.390.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.12.005"},{"key":"2025101721324044000_102.5.390.7","doi-asserted-by":"publisher","DOI":"10.1086\/675984"},{"key":"2025101721324044000_102.5.390.8","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfs173"},{"key":"2025101721324044000_102.5.390.9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.094722"},{"key":"2025101721324044000_102.5.390.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.006980"},{"key":"2025101721324044000_102.5.390.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.04.051"},{"key":"2025101721324044000_102.5.390.12","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.04488"},{"key":"2025101721324044000_102.5.390.13","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300569"},{"key":"2025101721324044000_102.5.390.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.08.002"},{"key":"2025101721324044000_102.5.390.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.905"},{"key":"2025101721324044000_102.5.390.16","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.203"},{"key":"2025101721324044000_102.5.390.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.019"},{"key":"2025101721324044000_102.5.390.18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35070"},{"key":"2025101721324044000_102.5.390.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2012.06.014"},{"key":"2025101721324044000_102.5.390.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2012.04.009"},{"key":"2025101721324044000_102.5.390.21","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000147181.65298.4D"},{"key":"2025101721324044000_102.5.390.22","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.O-06-449"},{"key":"2025101721324044000_102.5.390.23","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-013-0354-3"},{"key":"2025101721324044000_102.5.390.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887"},{"key":"2025101721324044000_102.5.390.25","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00048.2010"},{"key":"2025101721324044000_102.5.390.26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05701.x"},{"key":"2025101721324044000_102.5.390.27","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300287"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2015-308365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T04:32:52Z","timestamp":1760761972000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2015-308365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,10]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,2,10]]},"published-print":{"date-parts":[[2016,3,1]]}},"alternative-id":["10.1136\/heartjnl-2015-308365"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2015-308365","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,10]]}}}